Any observations regarding changes in body weight or metabolic parameters that arise within controlled experimental protocols should not be generalized beyond those research settings
Your provider may review: Sleep history Current sleep schedule Mental health symptoms Stress and burnout Medications and supplements Caffeine, alcohol, or substance use Hormonal or metabolic concerns Pain or inflammation Breathing concerns during sleep Prior sleep treatments Safety considerations If DSIP is not appropriate, your provider can help you explore other options that may better fit your needs
Advantage: Convenient, familiar, non-invasive Challenge: Peptides face proteolytic degradation in the stomach and small intestine Bioavailability: Estimated at approximately 38% based on comparative pharmacology (see below) Transdermal (Patch) Some researchers have explored transdermal patches to deliver peptides: Advantage: Avoids first-pass metabolism and GI degradation Challenge: Intact skin is a strong barrier to peptide penetration Feasibility: Not commonly available commercially
Regional: 35 business days
It is crucial to consult with a healthcare provider to determine if this treatment is appropriate and to receive proper training on how to administer the injections safely
Research has documented BPC-157s neuroprotective and neuroregenerative effects across multiple central and peripheral nervous system injury models
